PATENT CLAIM ANALYSIS

Application Number: 15982593
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-11
Patent Classification: ["424", "469000"]

Abstract:
The invention relates to an oral tablet for delivery of active ingredients to the gastrointestinal tract comprising a population of particles and an active ingredient to be delivered to the gastrointestinal tract, the population of particles comprising directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas, and the non-DC areas resulting in induced saliva generation upon mastication of the tablet, wherein the tablet is designed to be masticated and designed to deliver the active ingredient to the gastrointestinal tract as part of the saliva generated upon mastication of the tablet.

Claim (Index 103):
The oral chewable tablet according to  claim 96 , wherein the tablet comprises means for sustained release.

Metadata:
- Claim Count in Document: 95.0
- Percentile: 93.0
- Lexical Diversity: 2.09259
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15783722', '15356175', '12819907', '15958512', '12057177']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7126829322859498
- 35 USC 102 Novelty (BERT): 0.5292790881255236
- Combined Prediction Score: 0.6943425478699072
- Mean Citation Score: 236.236598
- Max Citation Score: 303.07114
- Similarity Product: 183.9026524481154

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test